Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of $0.04, $0.13 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $78 million versus the consensus estimate of $72.53 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.